Publicacións nas que colabora con JANNETTE RODRIGUEZ PALLARES (9)

2024

  1. Non-HLA angiotensin-type-1 receptor autoantibodies mediate the long-term loss of grafted neurons in Parkinson’s disease models

    Stem Cell Research and Therapy, Vol. 15, Núm. 1

2023

  1. Combined cell-based therapy strategies for the treatment of Parkinson's disease: Focus on mesenchymal stromal cells

    Neural Regeneration Research, Vol. 18, Núm. 3, pp. 478-484

2021

  1. Dopamine regulates adult neurogenesis in the ventricular-subventricular zone via dopamine D3 angiotensin type 2 receptor interactions

    Stem Cells, Vol. 39, Núm. 12, pp. 1778-1794

  2. Dose-dependent effect of mesenchymal stromal cells co-grafted with dopaminergic neurons in a Parkinson's disease rat model

    Journal of Cellular and Molecular Medicine, Vol. 25, Núm. 20, pp. 9884-9889

  3. Nrf2 activation and downstream effects: Focus on parkinson’s disease and brain angiotensin

    Antioxidants, Vol. 10, Núm. 11

2019

  1. Interaction between Angiotensin Type 1, Type 2, and Mas Receptors to Regulate Adult Neurogenesis in the Brain Ventricular-Subventricular Zone

    Cells, Vol. 8, Núm. 12

2018

  1. Angiotensin II induces oxidative stress and upregulates neuroprotective signaling from the NRF2 and KLF9 pathway in dopaminergic cells

    Free Radical Biology and Medicine, Vol. 129, pp. 394-406

  2. Data on the effect of Angiotensin II and 6-hydroxydopamine on reactive oxygen species production, antioxidant gene expression and viability of different neuronal cell lines

    Data in Brief

  3. Prostaglandin EP2 Receptors Mediate Mesenchymal Stromal Cell-Neuroprotective Effects on Dopaminergic Neurons

    Molecular Neurobiology, Vol. 55, Núm. 6, pp. 4763-4776